Our Portfolio

Deerfield portfolio companies strive to advance healthcare in meaningful and innovative ways.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Industry
Clear
Purpose of Financing
Clear
Stage
Clear
Structure of Financing
Clear
Status of Investment
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
:
Tag
Showing 0 of 100
Axon Therapies
Axon Therapies
Medical Technologies
Jan 2019
Venture
Early Stage
Equity
Current
BiomX
BiomX
Therapeutics
Mar 2024
Current
Bitterroot
Bitterroot
Therapeutics
May 2021
Venture
Seed/Startup
Debt and Equity
Current
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Healthcare Services
Feb 2023
Venture
Early Stage
Equity
Current
Aviko Radiopharmaceuticals
Aviko Radiopharmaceuticals
Therapeutics
Sep 2021
Venture
Seed/Startup
Equity
Current
ARS Pharmaceuticals
ARS Pharmaceuticals
Therapeutics
Sep 2018
Venture
Mid Stage
Equity
Current
Appello Pharmaceuticals
Appello Pharmaceuticals
Therapeutics
Apr 2018
Venture
Seed/Startup
Debt and Equity
Current
Apertura Gene Therapy
Apertura Gene Therapy
Therapeutics
May 2021
Venture
Seed/Startup
Equity
Current
Annexon
Annexon
Therapeutics
Jun 2020
Growth
Mid Stage
Equity
Current
Alo
Alo
Healthcare Services
Jun 2021
Venture
Seed/Startup
Equity
Current
AlivaMab Biologics
AlivaMab Biologics
Healthcare Services
May 2018
Venture
Seed/Startup
Equity
Current
Advanced Medicine Partners
Advanced Medicine Partners
Healthcare Services
Apr 2023
Venture
Growth
Debt
Current
Alector
Alector
Therapeutics
Jul 2018
Growth
Mid Stage
Equity
Current
Advantia Health
Advantia Health
Healthcare Services
Jan 2016
Growth
Mid Stage
Equity
Current
Adela
Adela
Medical Technologies
Mar 2021
Venture
Seed/Startup
Equity
Current
DISCLAIMER

The portfolio companies shown represents a significant portion of the current portfolio of Deerfield funds utilizing the Private Design Strategy or Healthcare Innovations Strategy.  Exclusions include historical investments, research projects and related entities, companies in stealth mode, companies without material operations, companies in which Deerfield funds hold residual interests, investments in other funds, and investment portfolios of other Deerfield strategies. The specific portfolio companies identified are not representative of all of the portfolio companies purchased, sold, or recommended for Deerfield funds, and it should not be assumed that any investment in an identified portfolio company was or will be profitable. Actual holdings will vary for each Deerfield fund and there is no guarantee that a particular Deerfield fund will hold any or all of the portfolio companies listed.